The preparative separation of dimetindene (CAS 5636-83-9) enantiomers
was achieved by fractionated crystallization of the diastereomeric tar
trate salts. HPLC on alpha-AGP (alpha(1)-acid glycoprotein) was used f
or confirmation of the enantiomeric purity. After administration of th
e enantiomers to rats the AUC and C-max of S(+)dimetindene and (-)N-de
methyldimetindene were slightly increased. In agreement with the serum
concentration data significantly more (-)N-demethyldimetindene was ex
creted into urine after administration of the individual enantiomers.
S(+)dimetindene was metabolised to a lesser extent in vivo (see above)
as well as in vitro in rat liver homogenate. After prior enzyme induc
tion conversion of the enantioselectivity with respect to unmetabolise
d dimetindene occurred. 6-Methoxydimetindene, 6-hydroxydimetindene and
6-hydroxy-N-demethyldimetindene were synthesized. 6-Methoxydimetinden
e is likely to be a metabolite since the retention times of synthetic
compound and the substance extracted from serum and urine are identica
l. The formation of 6-hydroxy-N-demethyldimetinedene was proved for th
e first time by comparison of the mass spectra of metabolite isolated
from in vitro incubations and synthetic compound after derivatisation
with acetic anhydride.